Skip to main content

Tamiflu News

Fourth Dairy Worker Infected With Bird Flu, but CDC Says Public Risk Still Low

WEDNESDAY, July 3, 2024 – Amid an ongoing outbreak of bird flu in dairy cows, a fourth case of H5N1 avian flu has been confirmed in another dairy worker, U.S. health officials reported Wednesday....

'Dual Mutant' Seasonal Flu Virus Could Make Some Treatments Ineffective

THURSDAY, June 13, 2024 – Two human cases of "dual mutant" strains of H1N1 flu have been reported by U.S. health officials. Unfortunately, the genetic changes appear to render the leading flu...

Doctors Describe Texas Dairy Farm Worker's Case of Bird Flu

FRIDAY, May 3, 2024 – Doctors in Texas are describing the only known human case of H5N1 avian flu connected to the ongoing outbreak of the disease in dairy cows. Bird flu in humans remains extremely...

Most Kids With the Flu Miss Out on Antiviral Tamiflu

TUESDAY, Nov. 14, 2023 – Children stricken with influenza aren’t receiving the flu-busting antiviral drug Tamiflu even though it’s recommended for them, a new study says. Three of five children with ...

Fighting the New Coronavirus in the Absence of a Proven Therapy

February 3, 2020 – While researchers race to develop a new Coronavirus vaccine, doctors are using currently available drugs to treat severe cases of the virus. Several patients have seen an...

FDA Expands Tamiflu's Use to Treat Children Younger Than One Year

December 21, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have shown symptoms of flu for no...

FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) for Oral Suspension: Label Change-New Concentration (6 mg/mL)

Patients may potentially receive either concentration (6 mg/mL or 12 mg/mL) from their pharmacy during the next influenza season (2011-2012). ISSUE: Labeling changes are being made to Tamiflu oral...

FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) - Mar 3, 2008

[Posted 03/04/2008] Roche and FDA informed healthcare professionals of neuropsychiatric events associated with the use of Tamiflu, in patients with influenza. These symptoms, as described in post...

FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) - Jan 4, 2007

Indication: Treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older who have been symptomatic for no more than 2 days.[Posted 01/04/2007] Roche notified...

FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) - Nov 13, 2006

[Posted 11/13/2006] Roche and FDA notified healthcare professionals of revisions to the PRECAUTIONS/Neuropsychiatric Events and Patient Information sections of the prescribing information for...

FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) Capsules and for Oral Suspension

Roche Laboratories and FDA notified healthcare professionals of new preclinical safety data that have implications for the use of Tamiflu in very young children. Preclinical findings in juvenile rats...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Influenza, Influenza Prophylaxis

Tamiflu patient information at Drugs.com